Cabaletta Bio

Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) this week announced that the Company’s fourth Investigational New Drug (IND) application for CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational …

Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis Read More



prodisc C Vivo and prodisc C SK

Chester County-based Centinel Spine Files PMA Application for Innovative Cervical Total Disc Replacement System

WEST CHESTER, PA — Centinel Spine®, LLC, a Chester County-based medical device company specializing in cervical and lumbar spinal disease solutions, has recently announced that the Food and Drug Administration …

Chester County-based Centinel Spine Files PMA Application for Innovative Cervical Total Disc Replacement System Read More